FDA approves Rukobia for the treatment of adults with multidrug-resistant HIV-1 infection July 3, 2020 No Comments
GlaxoSmithKline and collaborators identify NF-kappaB activators/HIV latency-reversing agents June 18, 2020 No Comments
FDA approves dispersible tablet formulation of dolutegravir for infants and children with HIV June 15, 2020 No Comments
RSS